Piet Ost
Researcher Next ID · RN-039827
Researcher · Medicine
HOGENT University of Applied Sciences and Arts
Ghent, Belgium
- Works count
- 609
- Citation count
- 19,375
- H-index
- 69
- i10-index
- 232
Research interests
Publications
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
European Urology · 2024 · https://doi.org/10.1016/j.eururo.2024.09.017
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
The Lancet Oncology · 2023 · https://doi.org/10.1016/s1470-2045(22)00752-5
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer · 2023 · https://doi.org/10.1016/j.ejca.2023.02.018
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
European Urology · 2022 · https://doi.org/10.1016/j.eururo.2022.04.002
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.00644
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
Nature Communications · 2021 · https://doi.org/10.1038/s41467-020-20493-6
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30718-1
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
European Urology · 2020 · https://doi.org/10.1016/j.eururo.2020.01.012
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.06.011
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review
European Urology · 2018 · https://doi.org/10.1016/j.eururo.2018.10.041
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
European Urology · 2017 · https://doi.org/10.1016/j.eururo.2017.06.002
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.75.4853
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.07.004
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology · 2014 · https://doi.org/10.1016/j.eururo.2014.09.004
Radiotherapy for renal-cell carcinoma
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(13)70569-2
Current projects
No projects listed.